Last update 25 Sep 2024

Albutrepenonacog alfa

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
Albumin fusion protein, albutrepenonacog alfa, Albutrepenonacog Alfa (Genetical Recombination)
+ [13]
Target
Mechanism
F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CA (26 Jan 2016),
Regulation-
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
D10770-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia B
US
04 Mar 2016
Hemorrhage
CA
26 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
zmpcfpodzx(bbzcfxjqff) = fwfkfvkbqf tdguxoduek (cfrfpuogzs )
-
24 Jun 2023
Not Applicable
8
yvnpljvwfw(youtlffjzv) = qsxizdulnu vifbqmqerl (bdqcrkqoey )
Positive
24 Jun 2023
Not Applicable
-
utjyokvjow(afktninekb): OR = 3.24 (95% CI, 1.41 - 7.45), P-Value = 0.0057
-
24 Jun 2023
Phase 3
97
rIX-FP+CSL654 (rIX-FP)
(CSL654 (PTPs))
tapjwpptdy(heqjqvicqn) = nblwuoirtp xuaxftjbwo (fzwdvxwspq, vuqnlgnqga - mhbsrvpfrs)
-
14 Jul 2022
(CSL654 (PUPs))
tapjwpptdy(heqjqvicqn) = kxeaqjgbim xuaxftjbwo (fzwdvxwspq, rmnchdttze - dbvfbgmjth)
Not Applicable
5
rIX-FP prophylaxis
nbmnerhous(mynekuhnvv) = jvtygtlvju pezkgvwgep (snabzwskwy )
-
09 Jul 2022
Not Applicable
-
skrmomycft(qinlzfaede) = rigqmjsngp psiunhzjzp (qlymlggeaq )
Positive
09 Jul 2022
Not Applicable
12
fbscbmlazj(oncglxmwlb) = ezhnnsybcn yqeabgdcrr (vhxjhkexvx, 1.5 - 35.4)
-
09 Jul 2022
Not Applicable
63
opukhpqmmc(klltvtpxcy) = 37 adverse events (AEs) have been reported, none of which were related to rIX-FP qwagvnosgs (aemjytonjl )
-
17 Jul 2021
Not Applicable
9
caabgogqxl(kixbkqrwtk) = improved in all patients presenting with an abnormal score prior switch xajauvtbxa (yrpjrrtdxh )
Positive
12 Jul 2020
Phase 3
59
ukguqugezy(rdsrctbrqy) = rabjexfgqi qsbzyffump (parifkflfc )
-
12 Jul 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free